Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells

G Wang1, S J M Jones, M A Marra

  • 1Genome Sciences Centre, BC Cancer Agency, Vancouver, British Columbia, Canada.

Oncogene
|June 6, 2006
PubMed

Insights

This study reveals how androgen and protein kinase A (PKA) pathways affect prostate cancer cell transcription. Limited gene cross-talk was observed between androgen receptor (AR) and PKA signaling pathways.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genomics

Background:

  • Prostate cancer progression to androgen independence is linked to androgen and protein kinase A (PKA) signaling.
  • Understanding the transcriptional changes in these pathways is crucial for cancer treatment.

Purpose of the Study:

  • To identify transcriptomes associated with androgen and PKA pathways in prostate cancer cells.
  • To discover common transcriptional targets regulated by both pathways.
  • To investigate the cross-talk between androgen receptor (AR) and PKA signaling.

Main Methods:

  • Utilized Affymetrix GeneChip technology (Human Genome U133 plus2) to analyze transcriptomes.
  • Employed GeneSpring software for statistical analysis of gene expression changes.
  • Validated gene expression using reverse transcriptase-polymerase chain reaction and Western blot analyses.
  • Used small interfering RNAs (siRNAs) to investigate androgen receptor (AR) regulation.

Main Results:

  • Identified 858 genes affected by androgen signaling and 303 genes by PKA pathway activation.
  • Validated 22 genes as transcriptional targets of androgen and/or PKA pathways.
  • Found that AR, activated by both androgen and PKA, regulates KLK3, KLK2, and SESN1 expression.
  • Determined that SESN1 is repressed by activated AR.

Conclusions:

  • Provided a comprehensive view of androgen and PKA pathway effects on prostate cancer cell transcription.
  • Demonstrated limited cross-talk between AR and PKA signaling pathways, targeting a small number of genes.
  • Highlighted the regulatory role of AR in genes like KLK2 and SESN1 in response to combined signaling.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.2K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
11.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K